Contact Us  





Division of Medical Oncology
University of Colorado Denver
12801 E. 17th Avenue
Aurora, CO  80010
Ph:  (303) 724-3888
Fax:  (303  724-3889
info@deptofmed.edu


 



William A. Robinson, MD, PhD.
Rella and Monroe Rifkin Endowed Chair
Professor

Education: MD University of Colorado 1962
PHD University of Melbourne, Australia 1968

University of Colorado at Denver
School of Medicine
Division of Medical Oncology
Tel: (303) 724-3888
Fax: (303) 724-1111
e-mail: william.robinson@uchsc.edu


Bio
Dr. Robinson, a native of Colorado, earned his medical degree from University of Colorado Medical School. He completed an internship and residency at The Massachusetts General Hospital and then returned to the University of Colorado as the Chief Resident in Internal Medicine in 1965.  He then did a PhD in Medical Biology and completed his fellowship at the The Walter and Eliza Hall Institute, University of Melbourne, Australia. He was one of the pioneers in the study of WBC regulation and was the first to describe and characterize human G-CSF.  Dr. Robinson joined the faculty of University of Colorado Denver in 1968 and was the first head of the Division of Medical Oncology. During his career Dr. Robinson has received many teaching and research awards and has been honored numerous times for his contributions to medicine, specifically medical oncology. He has also spent time in India as a Fulbright Scholar training junior doctors and doing research.  

Research
Dr. Robinson is an active clinical and basic investigator studying the molecular and genetic regulation of melanocyte development and melanoma, particularly the role of microRNAs in the regulation of melanoma associated genes. Together with Dr Lynn Bemis he is investigating the use of nano-technology to detect mutations in cancer cells. He is the founder of the melanoma tissue bank at CU which provides research materials to local investigators and numerous national and international collaborators.  He coordinates the Frontiers in Melanoma Seminar Program which brings in invited speakers from around the world for collaboration and discussion. In conjunction with the Dept of Dermatology he also has a major research effort in the genetics, molecular biology and development of giant congenital nevi.

 

FACULTY LIST

Lynn Bemis
Virginia Borges
Paul Bunn
David Calverley
Ross Camidge
Dan Chan
Gail Eckhardt
Anthony Elias
Thomas Flaig
Marileila Garcia
L. Michael Glode
Rene Gonzalez
Barb Helfrich
Fred Hirsch
Christopher Hogan
Antonio Jimeno
Madeleine Kane
Choon-Kee Lee
Stephen Leong
Wells Messersmith
Han Myint
Ana Oton
Peter Raich
William Robinson
Pepper Schedin
John Tentler
William Tse
Colin Weekes

Publications
Lewis KD, Robinson WA, McCarter M, Pearlman N, O’Day S, Anderson C, Gonzales R.   Phase II Study of Neoadjuvant Biochemotherapy for Stage III Malignant Melanoma. J Clin Oncol 24:3157-63, 2006.

 Ravdel L, Robinson WA, Lewis K, Gonzalez R. Metastatic melanoma in the breast: a report of 27 cases.J Surg Oncol. 94:101-4. 2006

 Pearlman N, McCarter MD, Frank M, Hurtubis C, Merkow RP, Franklin WA, Gonzalez R, Lewis K, Roaten JB, Robinson WA. Size of sentinel node metastases predicts other nodal disease and survival in  malignant melanoma. Am J Surg. 192:878-81. 2006

 Koyanagi K, O'Day SJ, Gonzalez R, Lewis K, Robinson WA, et al Microphthalmia transcription factor as a molecular marker for circulating tumor cell detection in blood of melanoma patients. Clin Cancer Res.12:1137-43. 2006

 Escodar GA, Robinson WA, Nydam, TL et al Severe paraneoplastic hypoglycemia in a patient with a gastrointestinal stromal tumor with an exon 9 mutation BMC Cancer 7:7-13 2007
 
 Swick BL, Ravdel L, Fitzpatrick JE, Robinson WA, Merkel cell carcinoma: Evaluation of KIT expression.J of Cutaneous Path 34:324-27. 2007


PubMed articles

Funding
Rifkin Endowment: $87,500 per year – ongoing
National Science Foundation. Nanoparticle detection of gene mutation. With Lynne Bemis. $1.1 million 9-1-06 – 8-31-09
Moore Family Foundation: $75,000 year: Melanoma Tissue Bank
SourceMD. Gene expression if peripheral blood of high risk melanoma patients $75,000/year 1-1-08 – 12-31-10


BACK TO TOP




Home  |  About  |  Faculty  |  Staff  |  Research  |  Clinical Trials  |  Fellowship 
Make a Donation  |  Employee Resources  |  Patient Information  |  Calendar
 
 
  Division of Medical Oncology
Copyright © 2008 University of Colorado Denver

Privacy Practices  
ds="14,39,391,97" href="../index.htm" />